Neuroprotective therapy of cerebrovascular insufficiency

One of the leading manifestations of chronic cerebrovascular diseases is impairment of cognitive and motor functions. Drugs recognized as neuroprotectors are used to correct such impairments. They intervene in and inhibit the pathogenetic cascade that results in the cell death in vascular pathology. The aim of the study is to evaluate the effectiveness of neuroprotective therapy for cerebrovascular insufficiency (CVI).